Pooling of faecal material results in standardized and high-richness microbiotherapy products MaaT013 and MaaT033

Previous PostPooled allogenic fecal microbiotherapy MaaT013 for the treatment of steroid-refractory gastrointestinal acute graft-versus-host disease: results from the phase IIa HERACLES study and expanded access program
Next PostDevelopment of a culture manufacturing process preserving the profile of gut microbiota for therapeutic purposes